BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND PPFIBP1, L2, 8496, ENSG00000110841, hSGT2, hSgt2p
519 results:

  • 1. Expression and prognostic significance of the PD-1/PD-L1 pathway in AIDS-related non-Hodgkin lymphoma.
    Zhao H; Cai S; Xiao Y; Xia M; Chen H; Xie Z; Tang X; He H; Peng J; Chen J
    Cancer Med; 2024 Apr; 13(7):e7195. PubMed ID: 38613207
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesis.
    Barisic D; Chin CR; Meydan C; Teater M; Tsialta I; Mlynarczyk C; Chadburn A; Wang X; Sarkozy M; Xia M; Carson SE; Raggiri S; Debek S; Pelzer B; Durmaz C; Deng Q; Lakra P; Rivas M; Steidl C; Scott DW; Weng AP; Mason CE; Green MR; Melnick A
    Cancer Cell; 2024 Apr; 42(4):583-604.e11. PubMed ID: 38458187
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Quantitative computed tomography analysis of body composition changes in paediatric patients with acute lymphoblastic leukaemia.
    Suwannaying K; Ong AA; Dhaduk R; Pei D; Iijima M; Merkle E; Zhuang TZ; Goodenough CG; Brown J; Browne EK; Wolcott B; Cheng C; Wilson CL; Pui CH; Ness KK; Kaste SC; Inaba H
    Br J Haematol; 2024 Apr; 204(4):1335-1343. PubMed ID: 38291722
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Genetic Characterization of Primary Mediastinal B-Cell lymphoma: Pathogenesis and Patient Outcomes.
    Noerenberg D; Briest F; Hennch C; Yoshida K; Hablesreiter R; Takeuchi Y; Ueno H; Staiger AM; Ziepert M; Asmar F; Locher BN; Toth E; Weber T; Amini RM; Klapper W; Bouzani M; Poeschel V; Rosenwald A; Held G; Campo E; Ishaque N; Stamatopoulos K; Kanellis G; Anagnostopoulos I; Bullinger L; Goldschmidt N; Zinzani PL; Bödör C; Rosenquist R; Vassilakopoulos TP; Ott G; Ogawa S; Damm F
    J Clin Oncol; 2024 Feb; 42(4):452-466. PubMed ID: 38055913
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Relationship between PD-L1 expression and tumor stem cell marker CD44 as a promising basis for the development of new approaches to cancer targeted therapy].
    Sotnikova TN; Polushkina TV; Danilova NV
    Arkh Patol; 2023; 85(6):70-75. PubMed ID: 38010641
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical Characteristics of Patients with Advanced ALK-Translocated Non-small Cell Lung Cancers and Long-Term Responses to Crizotinib (CRIZOLONG GFPC 05-19 Study).
    Dhamelincourt E; Descourt R; Rousseau-Bussac G; Doubre H; Decroisette C; Demontrond P; Le Garff G; Falchero L; Huchot E; Vieillot S; Corre R; Kazulinski L; Bizieux A; Bigay-Gamé L; Morel H; Molinier O; Chouaïd C; Guisier F
    Target Oncol; 2023 Nov; 18(6):905-914. PubMed ID: 37966566
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Neurolymphomatosis as an Initial Presentation of Non Hodgkins lymphoma: A Case Report.
    Rohatgi S; Nirhale S; Rao P; Naphade P; Khan F
    Neurol India; 2023; 71(5):991-993. PubMed ID: 37929441
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. RUNX1 rearrangement in mature B-cell acute lymphoblastic leukemia with non-L3 morphology.
    Yamamoto K; Kitao A; Watanabe M; Kanehira H; Joyce M; Hirakawa Y; Matsumoto S; Yakushijin K; Minami H
    J Clin Exp Hematop; 2023 Dec; 63(4):240-245. PubMed ID: 37899239
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Evaluation and Treatment of Primary Spinal Epidural lymphoma Presenting as Acute Myelopathy in a Young Adult: A Case Report.
    Cowley RA; Carroll AH; Pasko KBD; Rubenstein E; Tagouri YM; Weiner D
    JBJS Case Connect; 2023 Jul; 13(3):. PubMed ID: 37590426
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Anaplastic lymphoma Kinase Inhibitors for Therapy of Neuroblastoma in Adults.
    Stiefel J; Kushner BH; Roberts SS; Iglesias-Cardenas F; Kramer K; Modak S
    JCO Precis Oncol; 2023 Aug; 7():e2300138. PubMed ID: 37561984
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. HX009, a novel BsAb dual targeting PD1 x CD47, demonstrates potent anti-lymphoma activity in preclinical models.
    Ke H; Zhang F; Wang J; Xiong L; An X; Tu X; Chen C; Wang Y; Mao B; Guo S; Ju C; He X; Sun R; Zhang L; O'Connor OA; Li QX
    Sci Rep; 2023 Apr; 13(1):5419. PubMed ID: 37012357
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Waldenström Macroglobulinemia and Non-IgM-Type Lymphoplasmacytic lymphoma Are Genetically Similar.
    Awata-Shiraiwa M; Yokohama A; Kanai Y; Gotoh N; Kasamatsu T; Handa H; Saitoh T; Murakami H; Hirato J; Ikota H; Tsukamoto N
    Acta Haematol; 2023; 146(5):384-390. PubMed ID: 36917966
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Immune priming with avelumab and rituximab prior to R-CHOP in diffuse large B-cell lymphoma: the phase II AvR-CHOP study.
    Manos K; Chong G; Keane C; Lee ST; Smith C; Churilov L; McKendrick J; Renwick W; Blombery P; Burgess M; Nelson NE; Fancourt T; Hawking J; Lin W; Scott AM; Barraclough A; Wight J; Grigg A; Fong CY; Hawkes EA
    Leukemia; 2023 May; 37(5):1092-1102. PubMed ID: 36906715
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Primary lymphoma of the lumbar vertebrae: a case report and review of the literature.
    Safaei S; Azimi P; Yazdanian T; Molanaei S
    J Med Case Rep; 2023 Feb; 17(1):45. PubMed ID: 36774514
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Dysfunctions of innate and adaptive immune tumor microenvironment in Waldenström macroglobulinemia.
    Cholujova D; Beke G; Hunter ZR; Hideshima T; Flores L; Zeleznikova T; Harrachova D; Klucar L; Leiba M; Drgona L; Treon SP; Kastritis E; Dorfman DM; Anderson KC; Jakubikova J
    Int J Cancer; 2023 May; 152(9):1947-1963. PubMed ID: 36533670
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Cerebrospinal fluid soluble programmed death-ligand 1 is a useful prognostic biomarker in primary central nervous system lymphoma.
    Cheng CL; Yao CY; Huang PH; Yu CW; Fang WQ; Chuang WH; Wu SJ; Lin YJ; Hung YC; Tsai CH; Yu SC; Chou WC; Tien HF
    Br J Haematol; 2023 Apr; 201(1):75-85. PubMed ID: 36480431
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. PSR-Nets: Deep neural networks with prior shift regularization for PET/CT based automatic, accurate, and calibrated whole-body lymphoma segmentation.
    Wang M; Jiang H; Shi T; Wang Z; Guo J; Lu G; Wang Y; Yao YD
    Comput Biol Med; 2022 Dec; 151(Pt A):106215. PubMed ID: 36306584
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Study on bone microstructure and pathology of type L2 and L3 osteonecrosis of the femoral head specimens classified by China-Japan Friendship Hospital classification based on "three-columns structure"].
    Gao R; Xia X; Liu J; Yuan Z; Huan D; Shen J
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2022 Aug; 36(8):1003-1010. PubMed ID: 35979793
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Exome sequencing identifies PD-L2 as a potential predisposition gene for lymphoma.
    Shao J; Gao L; Leung ML; Gallinger B; Inglese C; Meyn MS; Del Gaudio D; Das S; Li Z
    Hematol Oncol; 2022 Aug; 40(3):475-478. PubMed ID: 35613340
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Programmed Death Ligand-1 is Frequently Expressed in Primary Acute Myeloid Leukemia and B-Acute Lymphoblastic Leukemia.
    Hamdan SO; Sughayer M; Khader M; Tbakhi A; Khudirat S; Hejazi A; AlRyalat S; Bustami N; Aladily TN
    Clin Lab; 2022 Apr; 68(4):. PubMed ID: 35443604
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 26.